Literature DB >> 19929216

Metabolic response and nutritional support in traumatic brain injury: evidence for resistance to renutrition.

Christine Charrueau1, Linda Belabed, Valérie Besson, Jean-Claude Chaumeil, Luc Cynober, Christophe Moinard.   

Abstract

Abstract Traumatic brain injury (TBI) is one of the most severe injuries encountered in intensive care units. TBI patients exhibit protein wasting and gastrointestinal dysfunction, which may be risk factors for a septic state. Specific nutritional support may be required for these patients, and we hypothesize that standard nutritional support does not allow restoration of the nutritional state of TBI patients. A well-validated rat model of TBI by fluid percussion was used. Rats were randomized into three groups: healthy rats receiving standard chow diet ad libitum (AL), rats sustaining TBI and receiving standard chow diet (TBI), and rats sustaining TBI and receiving a standard enteral diet (TBI-EN) for 4 days. TBI in rats was characterized by anorexia, body weight loss (AL: +15 +/- 5 g versus TBI: -11 +/- 4 g and TBI-EN: -8 +/- 4 g; p < 0.05), decrease in nitrogen balance (AL: 2.9 +/- 0.2 g versus TBI: 1.0 +/- 0.2 g and TBI-EN: 0.2 +/- 0.2 g, p < 0.05) associated with decrease in muscular protein content (extensor digitorum longus [EDL]: AL: 36 +/- 2 mg versus TBI: 26 +/- 3 mg and TBI-EN: 28 +/- 2 mg; p < 0.05), and intestinal atrophy (ileum: AL: 673 +/- 42 mg versus TBI: 442 +/- 23 mg and TBI-EN: 377 +/- 27 mg; p < 0.05). Interestingly, standard enteral nutrition was not effective in restoring any of these parameters. This work confirms that TBI is associated with profound nutritional alterations and has a major impact on nitrogen metabolism and on intestinal trophicity. It also demonstrates that using standard enteral nutrition cannot reverse this phenomenon. Thus, developing new nutritional strategies to cover TBI patients' specific nutritional requirements appears mandatory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929216     DOI: 10.1089/neu.2008.0737

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats.

Authors:  Kajal Bagri; Rahul Deshmukh
Journal:  Inflammopharmacology       Date:  2022-10-03       Impact factor: 5.093

Review 2.  [Nutritional therapy in traumatic brain injury : Update 2012].

Authors:  H E Marcus; F A Spöhr; B W Böttiger; S Grau; S A Padosch
Journal:  Anaesthesist       Date:  2012-08       Impact factor: 1.041

3.  Muscle atrophy in mechanically-ventilated critically ill children.

Authors:  Ryan W Johnson; Kay W P Ng; Alexander R Dietz; Mary E Hartman; Jack D Baty; Nausheen Hasan; Craig M Zaidman; Michael Shoykhet
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

4.  Metabolic response to maxillofacial trauma revisited: A retrospective study.

Authors:  V K Sasank Kuntamukkula; Ramen Sinha; Prabhat K Tiwari; Bharadwaj Bhogavaram; Himaja Subramanium; Bheema Vinod Kumar; Rahul V C Tiwari
Journal:  J Family Med Prim Care       Date:  2019-11-15

5.  Repetitive, mild traumatic brain injury results in a progressive white matter pathology, cognitive deterioration, and a transient gut microbiota dysbiosis.

Authors:  Mariana Angoa-Pérez; Branislava Zagorac; John H Anneken; Denise I Briggs; Andrew D Winters; Jonathan M Greenberg; Madison Ahmad; Kevin R Theis; Donald M Kuhn
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

Review 6.  Nutrition Therapy, Glucose Control, and Brain Metabolism in Traumatic Brain Injury: A Multimodal Monitoring Approach.

Authors:  Pedro Kurtz; Eduardo E M Rocha
Journal:  Front Neurosci       Date:  2020-03-24       Impact factor: 4.677

7.  Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects.

Authors:  Sher-Wei Lim; Hui-Chen Su; Tee-Tau Eric Nyam; Chung-Ching Chio; Jinn-Rung Kuo; Che-Chuan Wang
Journal:  BMC Neurosci       Date:  2021-09-14       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.